Quisinostat HCl is an inhibitor of histone deacetylase (HDAC) enzymes. HDAC inhibitors focus on HDAC enzymes, hindering the growth of cancer cells and triggering apoptosis, the programmed death of cancer cells. It also disrupts the HAT-dependent transcriptional repression complex in the nucleus to promote expression of genes involved in cellular proliferation. Reagent-grade; for laboratory research purposes only.
Products > Antibody Drug Conjugates (ADC), Oncology API > Oncology API
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye